SCHEMBL6162053

SCHEMBL6162053

NC(=O)ONC(=O)[CH]Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
MAOB P27338 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP2C19 P33261 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP2D6 P10635 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
PLA2G10 O15496 1/20 0.38
PLA2G2A P14555 1/20 0.38
NOS1 P29475 1/20 0.38
HPGD P15428 1/20 0.37
TOP1 P11387 1/20 0.37
PARP10 Q53GL7 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
HTT P42858 1/20 0.37
MMP1 P03956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345536 0.80 HTT (0.41) LMNAMAOBALDH1A1CYP2C19NPC1
SCHEMBL295277 0.77 MAOB (0.48) LMNAMAOBCYP2C19CA1CA2
SCHEMBL6582849 0.76 MAOB (0.43) LMNAMAOBALDH1A1CYP2C19NPC1
SCHEMBL4067815 0.74 TGM2 (0.55) MAOBALDH1A1HTTMMP1MMP2
SCHEMBL4073041 0.74 ALDH1A1 (0.62) LMNAALDH1A1CYP2C19CYP2D6HPGD
SCHEMBL18343734 0.74 ALDH1A1 (0.46) LMNAALDH1A1CYP2C19NPC1RAB9A
SCHEMBL6167127 0.73 TAAR1 (0.48) ALDH1A1CA12CA1CA2CA9
SCHEMBL27640145 0.73 MAOB (0.44) MAOBCYP2C19CA1CA2PLA2G10
SCHEMBL7749862 0.73 KMT2A (0.46) LMNAMAOBALDH1A1CYP2C19NPC1
SCHEMBL28020311 0.72 LMNA (0.43) LMNAALDH1A1CYP2C19CYP2D6CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed